Biopharma firm Ergomed has made two senior appointments as it looks to grow its business and expand its digital offering.
In a move to bolster its executive team, serving non-executive director at Ergomed, Michael Spiteri, has been named as the chief transformation and technology officer and Jonathan Curtain has been appointed as deputy chief financial officer.
A statement from the Guildford-based firm announcing the appointments read: "Amid the sustainable and strong momentum in Ergomed’s business in H122 despite market softness, we see that the new additions as underscoring the management’s focus on business expansion and digital transformation."
READ MORE: Anne Whitaker appointed to board of pharma firm Ergomed as non-executive director
Ergomed announced a total revenue for H1 2022 of £69.9 million, which is a year-on-year increase of 24.8 per cent.
Biopharma firm Ergomed acquired consultancy outfit ADAMAS, based in Crowthorne, in February for £25.6m.
The Ergomed group currently employs more than 1,500 people globally and operates out of 20 offices across the globe, providing its services in around 100 countries in total.
READ MORE: Biopharma firm Ergomed sees revenues grow by 25 per cent
Bath-based Future plc, the publisher of specialist online and print magazines, said trading in its…
The university of Bristol was one of six organisations to receive a contract from the…
Oxford BioDynamics Plc is teaming up with researchers at King's College London in a bid…
More than a quarter of a million extra construction workers are needed in the UK…
Kent-based housebuilder Vistry revealed it was on track to deliver more than 10% growth in…
A Dorset-based company, which has developed ground-breaking technology to recycle plastic waste and turn it…